S

Stoke Therapeutics

Develops targeted gene upregulation therapies

Senior Director - Quality Control

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBedford, MA, USA

About the Job

Requirements

  • A BS/BA, MS, or PhD in Analytical Sciences or another relevant discipline, such as chemistry or biology.
  • At least 15 years of progressive quality control experience spanning late-stage development and commercialization, with significant leadership responsibility.
  • Strong working knowledge of Good Manufacturing Practice (GMP), data integrity principles, and International Council for Harmonisation (ICH) guidelines.
  • Demonstrated expertise in analytical method validation, lifecycle management, and control strategy development.
  • Experience preparing regulatory filings and messaging across global jurisdictions.
  • Ability to set high standards for performance and accountability and to clarify expectations and outcomes.
  • Conflict resolution, management, and negotiation skills.
  • Leadership ability to influence, collaborate, and communicate effectively in a cross-functional organization.
  • Seasoned quality control leadership experience, including analytical method lifecycle management and successful collaboration with Contract Manufacturing Organizations (CMOs) and Contract Testing Laboratories (CTLs).
  • Working knowledge of relevant Food and Drug Administration (FDA), European Union (EU), and ICH GMP guidelines and regulations and their phase-appropriate application to product development.
  • Pragmatic, risk-based judgment for product development and quality management, and willingness to contribute directly to process implementation, technical development, and issue resolution.

Responsibilities

  • Establish and lead the global quality control strategy for all stages of product development in alignment with Chemistry, Manufacturing, and Controls (CMC).
  • Serve as a quality control subject matter expert and thought partner to senior leadership.
  • Establish and maintain a phase-appropriate analytical control strategy supporting clinical development, global regulatory filings, and commercialization.
  • Oversee the lifecycle management of analytical methods for oligonucleotide products, including method transfer, qualification, validation, optimization, stability testing, specification justification and maintenance, shelf-life management, reference standard management, and remediation.
  • Lead the quality control group responsible for routine GMP in-process, release, and stability testing, and establish the long-term quality control testing strategy for clinical and commercial programs.
  • Lead selection, governance, and performance management of Contract Testing Laboratories (CTLs), ensuring technical support, compliance, and consistent delivery.
  • Partner with CMC, Quality Assurance, Regulatory Affairs, and program teams to ensure quality control strategies support the overall control strategy.
  • Provide leadership and technical input for CMC and analytical sections of regulatory submissions, including IND, NDA, IMPD, and MAA filings.
  • Support interactions with health authorities, Stoke partners, and CTLs as a quality control and analytical expert.
  • Interpret GMP compliance requirements, provide consultation and training, and ensure data integrity for all quality control activities.
  • Develop Stoke’s quality control infrastructure and implement processes and procedures to support therapeutic candidate development in a GMP-compliant manner.
  • Drive continuous improvement initiatives across Quality Control.
  • Support the GMP inspection preparation program and mock pre-approval inspections at CTLs and CMOs as necessary.
  • Influence Stoke’s quality culture.
  • Lead, mentor, and develop a small team of quality control professionals.

About the Company

Stoke Therapeutics

Develops targeted gene upregulation therapies

Stoke Therapeutics develops therapies for severe genetic diseases caused by loss of function in a single gene, aiming to restore missing proteins by upregulating protein expression. Its main product approach relies on the TANGO (Targeted Augmentation of Nuclear Gene Output) platform, which delivers precise, durable, and controllable upregulation of gene expression across a range of tissues to re-create the missing protein. Compared with many biotech firms, Stoke centers on upregulating endogenous gene output rather than replacing genes or adding new ones, and focuses on disease-modifying treatments for rare disorders with unmet medical needs. Revenue comes from partnerships, licensing agreements, and, ultimately, commercialization of its therapies. The company’s goal is to provide targeted, durable treatments that address the underlying genetic deficiency and improve outcomes for patients with limited options.

Company size
201-500
Company stage
IPO
Headquarters
Bedford, TX
Founded
2014

Recently Posted Jobs

Explore more opportunities at Stoke Therapeutics

See more jobs